Searched for
ANTHEM BIOSCIENCES GMP
Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...- Bharat Coking Coal IPO GMP holds strong at nearly 60% as listing gets postponedBharat Coking Coal IPO’s grey market premium remains near 60% despite a delay in listing due to a trading holiday. The issue saw massive in...
- Anthem Biosciences shares list at 27% premium over IPO priceAnthem Biosciences share price listed at a premium after its IPO. The IPO was subscribed 67.4 times. Qualified institutional buyers showed ...
- Anthem Biosciences IPO: What GMP signals ahead of listing on MondayAnthem Biosciences will debut on stock exchanges on Monday, July 21, with grey market signals suggesting a potential 29% listing gain over ...
- Anthem Biosciences IPO subscribed 4x on last day; Check GMP, and other key detailsAnthem Biosciences IPO GMP: The IPO attracted strong interest, receiving bids for 17.66 crore shares against 4.4 crore shares on offer. Non...
- Anthem Biosciences IPO allotment out today; GMP strong ahead of listingAnthem Biosciences IPO allotment date: The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin T...
- Anthem Biosciences IPO subscribed 2x on day 2; Check GMP, and other key detailsAnthem Biosciences' IPO witnessed strong investor interest, being oversubscribed 2.08 times on Day 2, driven by NIIs. Brokerages recommend ...
- Anthem Biosciences' Rs 3,395 crore IPO opens for subscription. Should you bid?Anthem Biosciences launched its IPO on July 14, featuring an offer for sale of Rs 3,395 crore. The Bengaluru-based CRDMO, with a price band...
- Indo Farm Equipment IPO Day 2: Check subscription status, GMP, price band and other detailsThe IPO of Indo Farm Equipment received strong investor response on its opening day, getting subscribed 6.94 times. The offering included b...
Load More
